The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies
<p>The gut-microbiome has been hypothesised as a novel potential target for intervention for schizophrenia.</p> <p>We tested this hypothesis with a systematic review and meta-analysis of studies investigating the efficacy and acceptability of add-on strategies known to affect the...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2020
|
| _version_ | 1826304522018881536 |
|---|---|
| author | Minichino, A Brondino, N Solmi, M Del Giovane, C Fusar-Poli, P Burnet, P Cipriani, A Lennox, B |
| author_facet | Minichino, A Brondino, N Solmi, M Del Giovane, C Fusar-Poli, P Burnet, P Cipriani, A Lennox, B |
| author_sort | Minichino, A |
| collection | OXFORD |
| description | <p>The gut-microbiome has been hypothesised as a novel potential target for intervention for schizophrenia.</p>
<p>We tested this hypothesis with a systematic review and meta-analysis of studies investigating the efficacy and acceptability of add-on strategies known to affect the gut-microbiome for the treatment of schizophrenia.</p>
<p>Following PRISMA guidelines, we searched from inception to August 2019 all the randomised double-blind controlled trials of add-on antibiotics, antimicrobials, pre/probiotics, and faecal transplant in schizophrenia. Primary outcomes were severity of negative symptoms and acceptability of treatment. Data were independently extracted by multiple observers and a random-mixed model was used for the analysis. Heterogeneity was assessed with the I2 index.</p>
<p>We identified 28 eligible trials: 21 investigated antibiotics, 4 antimicrobials (Artemisinin, Artemether, and Sodium Benzoate), 3 pre/probiotics, none faecal transplant.</p>
<p>Results showed no effect of D-Cycloserine (10 studies; SMD, −0.16; 95% CI −0.40, 0.08; P = .20; I2: 28.2%), Minocycline (7 studies; SMD: −0.35; 95% CI −0.70, 0.00; P = .05, I2:77.7%), other antibiotics (2 studies), probiotics alone (1 study), and Artemisinin (1 study) on negative symptoms of schizophrenia when compared to placebo. Limited evidence suggests efficacy on negative symptoms for Sodium benzoate (2 studies; SMD, −0.63; 95%CI −1.03, −0.23; P < .001; I2:0%), Artemether (1 study), and probiotics combined with Vitamin D (1 study) when compared to placebo. Acceptability of intervention was similar to placebo.</p>
<p>Negative findings were mainly led by antibiotics trials, with paucity of evidence available on pre/probiotics. There is a need of expanding our knowledge on the clinical relevance of gut-microbiome-host interaction in psychosis before engaging in further trials.</p>
|
| first_indexed | 2024-03-07T06:19:05Z |
| format | Journal article |
| id | oxford-uuid:f21c28a3-33ce-484a-867a-f632c0681a79 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:19:05Z |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:f21c28a3-33ce-484a-867a-f632c0681a792022-03-27T12:01:10ZThe gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f21c28a3-33ce-484a-867a-f632c0681a79EnglishSymplectic ElementsElsevier2020Minichino, ABrondino, NSolmi, MDel Giovane, C Fusar-Poli, PBurnet, PCipriani, ALennox, B<p>The gut-microbiome has been hypothesised as a novel potential target for intervention for schizophrenia.</p> <p>We tested this hypothesis with a systematic review and meta-analysis of studies investigating the efficacy and acceptability of add-on strategies known to affect the gut-microbiome for the treatment of schizophrenia.</p> <p>Following PRISMA guidelines, we searched from inception to August 2019 all the randomised double-blind controlled trials of add-on antibiotics, antimicrobials, pre/probiotics, and faecal transplant in schizophrenia. Primary outcomes were severity of negative symptoms and acceptability of treatment. Data were independently extracted by multiple observers and a random-mixed model was used for the analysis. Heterogeneity was assessed with the I2 index.</p> <p>We identified 28 eligible trials: 21 investigated antibiotics, 4 antimicrobials (Artemisinin, Artemether, and Sodium Benzoate), 3 pre/probiotics, none faecal transplant.</p> <p>Results showed no effect of D-Cycloserine (10 studies; SMD, −0.16; 95% CI −0.40, 0.08; P = .20; I2: 28.2%), Minocycline (7 studies; SMD: −0.35; 95% CI −0.70, 0.00; P = .05, I2:77.7%), other antibiotics (2 studies), probiotics alone (1 study), and Artemisinin (1 study) on negative symptoms of schizophrenia when compared to placebo. Limited evidence suggests efficacy on negative symptoms for Sodium benzoate (2 studies; SMD, −0.63; 95%CI −1.03, −0.23; P < .001; I2:0%), Artemether (1 study), and probiotics combined with Vitamin D (1 study) when compared to placebo. Acceptability of intervention was similar to placebo.</p> <p>Negative findings were mainly led by antibiotics trials, with paucity of evidence available on pre/probiotics. There is a need of expanding our knowledge on the clinical relevance of gut-microbiome-host interaction in psychosis before engaging in further trials.</p> |
| spellingShingle | Minichino, A Brondino, N Solmi, M Del Giovane, C Fusar-Poli, P Burnet, P Cipriani, A Lennox, B The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies |
| title | The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies |
| title_full | The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies |
| title_fullStr | The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies |
| title_full_unstemmed | The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies |
| title_short | The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies |
| title_sort | gut microbiome as a target for the treatment of schizophrenia a systematic review and meta analysis of randomised controlled trials of add on strategies |
| work_keys_str_mv | AT minichinoa thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT brondinon thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT solmim thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT delgiovanec thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT fusarpolip thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT burnetp thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT cipriania thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT lennoxb thegutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT minichinoa gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT brondinon gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT solmim gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT delgiovanec gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT fusarpolip gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT burnetp gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT cipriania gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies AT lennoxb gutmicrobiomeasatargetforthetreatmentofschizophreniaasystematicreviewandmetaanalysisofrandomisedcontrolledtrialsofaddonstrategies |